<!-- Dyna-to-Html Version 1.2 - Copyright (c) 2018 Alain J. Michiels. All rights reserved. -->
<html>
<head>
<style>
body {font-family: Verdana, Geneva, sans-serif; font-size: 14px; background-color: white;}
p {margin-left: 14px;}
ol {margin-top: -10px; margin-left: 15px; padding-left: 15px;}
ul {margin-top: -10px; margin-left: 15px; padding-left: 15px;}
pre {display: block; font-family: monospace; white-space: pre; margin: 1em 0; font-size: 16px;}
ol.ref {margin-top: -10px; margin-left: 36px; padding-left: 0; text-indent: -22px; list-style-position: outside; list-style-type: none; counter-reset: icnt;}
ol.ref li.ref::before {content: '[' counter(icnt) '] '; counter-increment: icnt;}
</style>
<script async="" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS_CHTML" type="text/javascript"></script>
<meta http-equiv="Content-Type" content="text/html;charset=ISO-8859-1">
</head>
<body>
<h1 align="center" style="color:#7EAEAC">Leukemia</h1>
<pre>
<font color="red"><b>rem:</b></font> Leukemia
</pre>
<p>
  We study the optimal control of leukemic cell population presented in [2], namely the optimal use
  of a combination of cytostatic and cytotoxic drugs in order to reduce the total cancerous cells.
  The model from [1] and [3] considers two sub-populations of leukemic cells: the inactive resting
  cells, and the proliferating cells. Resting cells go into the proliferating phase at constant
  rate \(\beta\). Proliferating cells either die by apoptosis with rate \(\gamma\) or divide during
  mitosis into two daughter cells. Mitosis has a duration of \(2\tau\) and the daughter cells start
  in the resting phase. We introduce the age variable a for the time spent in the proliferating
  phase, and note \(R(t)\) the resting population and \(p(a,t)\) the proliferating population. We
  consider two drugs: a cytotoxic that induces a death rate \(u(t)\) in the second half of the
  proliferating phase, and a cytostatic \(v(t)\) that results in a fraction \(k(t)\) of inhibited
  resting cells that are blocked from entering the proliferating phase.
<p>
  The system follows the dynamics:
<p>
  \[
  \begin{array}{ll}
  \frac{dR}{dt}(t) = -(1-k(t)) \beta R(t) + 2p(t,2\tau)\\
  \frac{dk}{dt}(t) = v(t) (1-k(t)) - \alpha k(t)\\
  \frac{\partial p}{\partial t}(t,a) + \frac{\partial p}{\partial a}(t,a) = -(\gamma + \chi_{(\tau,2\tau)}(a)u(t)) p(t,a),\ 2 \lt a \lt 2\tau\\
  p(t,0) = (1-k(t)) \beta R(t)
  \end{array}
  \]
<p>
  In order to handle the transport equation for \(p\), we note the total and second half
  proliferating populations
<p>
  \[
  P(t) = \int_0^{2\tau} p(t,a)\ \mathrm{d}a, \quad P_2(t) = \int_\tau^{2\tau} p(t,a)\ \mathrm{d}a
  \]
<p>
  As detailed in [1] and [2], by the method of characteristics the dynamics can be rewritten as a
  system of delay differential equations corresponding to a controlled version of Mackey&rsquo;s model
  [3].
<p>
  \[
  \begin{array}{ll}
  \frac{dR}{dt}(t) = & -(1-k(t)) \beta R(t) + 2(1-k(t-2\tau)\beta R(t-2\tau)e^{-(\gamma 2 \tau + \int_{t-\tau}^\tau u(s) \ \mathrm{d}s)}\\
  \frac{dP}{dt}(t) = & -(\gamma P(t) + u(t)P_2(t)) + (1-k(t))\beta R(t) \\
                     & - (1-k(t-2\tau))\beta R(t-2\tau) e^{-(\gamma 2 \tau + \int_{t-\tau}^\tau u(s) \ \mathrm{d}s)}\\
  \frac{dP_2}{dt}(t) = & -(\gamma + u(t)P_2(t)) + (1-k(t-\tau))\beta R(t-\tau)e^{-\gamma \tau}\\
                       & - (1-k(t-2\tau))\beta R(t-2\tau) e^{-(\gamma 2 \tau + \int_{t-\tau}^\tau u(s) \ \mathrm{d}s)}\\
  \frac{dk}{dt}(t) = & v(t) (1-k(t)) - \alpha k(t)
  \end{array}
  \]
<p>
  We refer the reader to [2] for the formal analysis of this system, namely the existence of
  solutions and the introduction of age-weighted populations \(\tilde{P}\), \(\tilde{P}_2\) to
  counteract the horizon effect that would cause to always stop all treatment at the end of the
  time interval. Taking into account constraints on the maximal cumulative dose of drugs, the
  resulting optimal control problem writes as
<p>
  \[
  \begin{array}{l}
  \min \ R(T) + \tilde{P}(T)\\
  \frac{dR}{dt}(t) = -(1-k(t)) \beta R(t) + \tilde{p}(t,2\tau)\\
  \frac{d\tilde{P}}{dt}(t) = \lambda \tilde{P}(t) - u(t) \tilde{P}_2(t) + \tilde{p}(t,0) - \tilde{p}(t,2\tau)\\
  \frac{d\tilde{P}_2}{dt}(t) = (\lambda - u(t)) \tilde{P}_2(t) + \tilde{p}(t,\tau) - \tilde{p}(t,2\tau)\\
  \frac{dk}{dt}(t) = v(t) (1-k(t)) - \alpha k(t)\\
  0 \le u(t) \le \bar{u}, \quad 0 \le v(t) \le \bar{v}\\
  \int_0^T u(t) \ \mathrm{d}t \le \bar{U}
  \end{array}
  \]
<p>
  where \(\lambda\) is defined by the equation \(\lambda + \beta = 2 \beta e^{-(\lambda+\gamma) 2 \tau} \) and
<p>
  \[
  \begin{array}{l}
  \tilde{p}(t,0) = (1-k(t))(\lambda+\beta)R(t)\\
  \tilde{p}(t,\tau) = (1-k(t-\tau))(\lambda+\beta)R(t-\tau)e^{\lambda \tau}\\
  \tilde{p}(t,2\tau) = (1-k(t-2\tau))(\lambda+\beta)R(t-2\tau)e^{\lambda 2\tau - y(t)}\\
  y(t) = \int_{t-\tau}^t u(s)\ \mathrm{d}s
  \end{array}
  \]
<p>
  with the border cases
<p>
  \[
  \begin{array}{ll}
  \tilde{p}(t,\tau) = p_0(\tau-t)2 e^{-\gamma t - (\lambda+\gamma)\tau} \ \text{if}\ t \lt \tau\\
  \tilde{p}(t,2\tau) = p_0(2\tau-t)2 e^{-\gamma t - y(t)} \ \text{if}\ t \lt 2\tau \\
  y(t) = \int_0^t u(s)\ \mathrm{d}s \ \text{if}\ t \lt \tau\\
  \end{array}
  \]
<p>
  From [2] we take the initial conditions
<p>
  \[
  R(0)=R_0 = 4\ 10^5,\ k(0)=0,\ y(0)=0,\\
  \tilde{P}(0)=\int_0^{2\tau}e^{(\lambda+\gamma)(a-2\tau)}p_0(a)\ \mathrm{d}a, \quad \tilde{P}_2(0)=\int_\tau^{2\tau}e^{(\lambda+\gamma)(a-2\tau)}p_0(a)\ \mathrm{d}a\\
  \]
<p>
  and the parameters
<p>
  \[
  T=5,\ \tau=1,\ p_0(a)=0.5\ 10^5,\ \alpha=1,\ \beta=2,\ \bar{v}=2,\ \gamma=0.05.
  \]
<p>
  Numerical simulations are carried out for three cases:
  \(\bar u = 0.2\), \(\bar U = 2 \bar u\);
  \(\bar u = 1\), no limit \(\bar U\);
  and
  \(\bar u = 1\), \(\bar U = 2 \bar u\).
<p>
  References:
  <ol>
  <li>M. Adimy, F. Crauste and A. El Abdllaoui,
  <em>Discrete maturity-structured model of cell differentiation with applications to acute myelogenous leukemia</em>,
  Journal of Biological Systems, 16(3):395-424, 2008.
  <li>X. Dupuis,
  <em>Optimal control of leukemic cell population dynamics</em>,
  Mathematical Modelling of Natural Phenomena, 9(1):4-26, 2014.
  <li>M.C. Mackey,
  <em>Unified hypothesis for the origin of aplastic anemia and periodic hematopoiesis</em>,
  Blood, 51(5):941-956, 1978.
  </ol>
<p>
  See:
  <a href="https://project.inria.fr/bocop/leukemia/">
  BOCOP - The optimal control solver</a>.
<p>
<pre>
<font color="red"><b>run:</b></font>
  <font color="#39CCCC">substitute-symbols</font> = U&gt;uu | Ubar&gt;uubar
  <font color="#39CCCC">default-collocation-method</font> = L3A2
  <font color="#39CCCC">default-time-steps-number</font> = 12
  <font color="#39CCCC">gams-option</font> = reslim=7200

<font color="red"><b>par:</b></font>
  tau = 1
  alpha = 1
  beta = 2
  gamma = 0.05		<font color="#808080"><i># 0.05   | 0.15 | 0.05</i></font>
  p0 = 50000
  ubar = 1		<font color="#808080"><i># 0.2    | 1    | 1</i></font>
  vbar = 2
  Ubar = 2*ubar		<font color="#808080"><i># 2*ubar | +inf | 2*ubar</i></font>
  tf = 5

<font color="red"><b>gms:</b></font>
  <font color="#808080"><i># solve for lambda</i></font>
  <font color="#3D9970">variable</font> L,dummy;
  <font color="#3D9970">equation</font> equ,obj;
  equ.. L + beta =e= 2*beta*<font color="#2ECC40">exp</font>(-(L+gamma)*2*tau);
  obj.. dummy =e= 1;
  L.l = 0.25;
  <font color="#3D9970">model</font> detL /equ,obj/;
  <font color="#3D9970">solve</font> detL minimizing dummy using nlp;
  <font color="#3D9970">display</font> L.l;

<font color="red"><b>par:</b></font>
  lambda = L.l

<font color="red"><b>dyn:</b></font>
  <font color="#808080"><i># State variables</i></font>
  R		<font color="#808080"><i># resting cells</i></font>
  Ptilde	<font color="#808080"><i># proliferating cells phase 1+2 (weighted)</i></font>
  P2tilde	<font color="#808080"><i># proliferating cells phase 2 (weighted)</i></font>
  k		<font color="#808080"><i># fraction of inhibited (resting) cells</i></font>
  y		<font color="#808080"><i># effect of cytotoxic \int_t-tau^tau u(s)\ \mathrm{d}s</i></font>
  U		<font color="#808080"><i># cumulative cytotoxic dose</i></font>
  P		<font color="#808080"><i># non weighted populations		</i></font>
  P2		<font color="#808080"><i># non weighted populations</i></font>
  <font color="#808080"><i># Control variables</i></font>
  u		<font color="#808080"><i># cytotoxic</i></font>
  v		<font color="#808080"><i># cytostatic</i></font>

<font color="red"><b>lim:</b></font>
  0 &lt;= R &lt;= +<font color="#3D9970">inf</font>
  0 &lt;= Ptilde &lt;= +<font color="#3D9970">inf</font>
  0 &lt;= P2tilde &lt;= +<font color="#3D9970">inf</font>
  0 &lt;= k &lt;= +<font color="#3D9970">inf</font>
  0 &lt;= U &lt;= Ubar
  0 &lt;= P &lt;= +<font color="#3D9970">inf</font>
  0 &lt;= P2 &lt;= +<font color="#3D9970">inf</font>
  0 &lt;= u &lt;= ubar
  0 &lt;= v &lt;= vbar

<font color="red"><b>t=t0:</b></font>
  R = 400000
  Ptilde = 2*p0/(lambda+gamma)*(1-<font color="#2ECC40">exp</font>(-(lambda+gamma)*2*tau))
  P2tilde = 2*p0/(lambda+gamma)*(1-<font color="#2ECC40">exp</font>(-(lambda+gamma)*tau))
  k = 0
  y = 0
  U = 0
  P = p0*2*tau
  P2 = p0*tau

<font color="red"><b>ini:</b></font>
  R = <font color="#0074D9">initial</font>(R)/2
  Ptilde = R
  P2tilde = R/2
  k = 0.5
  y = 0
  U = 0
  P = p0*2*tau
  P2 = p0*tau
  u = 0
  v = 0

<font color="red"><b>sca:</b></font>
  R = 1e5
  Ptilde = 1e5
  P2tilde = 1e5
  k = 1e-1
  y = 1
  U = 1
  P = 1e5
  P2 = 1e5
  u = 1
  v = 1

<font color="red"><b>exp:</b></font>
  <font color="#808080"><i># ptilde(t,0)</i></font>
  pt0 == (1-k)*(lambda+beta)*R

  <font color="#808080"><i># ptilde(t,tau)</i></font>
  pttau == <font color="#2ECC40">ifthen</font>(<font color="#0074D9">Time</font> &lt; tau, \
    p0*2*<font color="#2ECC40">exp</font>(-gamma*<font color="#0074D9">Time</font>-(lambda+gamma)*tau), \
    (1-<font color="#0074D9">delay</font>(k,tau))*(lambda+beta)*<font color="#0074D9">delay</font>(R,tau)*<font color="#2ECC40">exp</font>(lambda*tau))

  <font color="#808080"><i># ptilde(t,2tau)</i></font>
  pt2tau == <font color="#2ECC40">ifthen</font>(<font color="#0074D9">Time</font> &lt; 2*tau, \
    p0*2*<font color="#2ECC40">exp</font>(-gamma*<font color="#0074D9">Time</font>-y), \
    (1-<font color="#0074D9">delay</font>(k,2*tau))*(lambda+beta)*<font color="#0074D9">delay</font>(R,2*tau)*<font color="#2ECC40">exp</font>(lambda*2*tau-y))

  uprev == <font color="#2ECC40">ifthen</font>(<font color="#0074D9">Time</font> &lt; tau, 0, <font color="#0074D9">delay</font>(u,tau))

  auxP0 == (1-k)*beta*R
  auxP == pttau * 0.5 * <font color="#2ECC40">exp</font>((lambda+gamma)*tau)
  auxP2 == pt2tau * 0.5

<font color="red"><b>equ:</b></font>
  R&acute; == -(1-k)*beta*R + pt2tau
  Ptilde&acute; == lambda*Ptilde - u*P2tilde + pt0 - pt2tau
  P2tilde&acute; == (lambda-u)*P2tilde + pttau - pt2tau
  k&acute; == v*(1-k) - alpha*k
  y&acute; == u - uprev
  U&acute; == u
  P&acute; == - gamma*P - u*P2 + auxP0 - auxP2
  P2&acute; == (-gamma-u)*P2 + auxP - auxP2

<font color="red"><b>obj:</b></font>
  <font color="#808080"><i># Knitro does a very good job here and much better than ipopt or conopt</i></font>
  <font color="#8A2BE2">minimize</font> <font color="#0074D9">final</font>(R)+<font color="#0074D9">final</font>(Ptilde) <font color="#8A2BE2">using</font> dnlp <font color="#8A2BE2">with</font> knitro|conopt
  
<font color="red"><b>gms:</b></font>
  <font color="#8A2BE2">@solveloop</font> Method=movavg, Paraml=3 0.95, Varl=u v, Target=infes, Maxiter=3
  <font color="#8A2BE2">@solveloop</font> Method=bndobj

</pre>
</body>
</html>
